You are here

Article info

Article menu

Download PDFPDF

Commentary
Should India be considering deployment of the first malaria vaccine RTS,S/AS01?

Authors

  • Manju Rahi Division of Epidemiology and Communicable Diseases, Indian Council of Medical Research, New Delhi, Delhi, India PubMed articlesGoogle scholar articles
  • Amit Sharma National Institute of Malaria Research, New Delhi, Delhi, IndiaMolecular Medicine, International Centre for Genetic Engineering and Biotechnology, New Delhi, Delhi, India PubMed articlesGoogle scholar articles
  1. Correspondence to Dr Manju Rahi; drmanjurahi{at}gmail.com
View Full Text

Citation

Rahi M, Sharma A
Should India be considering deployment of the first malaria vaccine RTS,S/AS01?
BMJ Global Health 2022;7:e007870.

Publication history

  • Received October 29, 2021
  • Accepted November 25, 2021
  • First published January 4, 2022.
Online issue publication 
October 18, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.